Cleared Traditional

K973014 - QUANTA LITE B2GPI IGM (FDA 510(k) Clearance)

Oct 1997
Decision
68d
Days
Class 2
Risk

K973014 is an FDA 510(k) clearance for the QUANTA LITE B2GPI IGM. This device is classified as a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II - Special Controls, product code MSV).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on October 20, 1997, 68 days after receiving the submission on August 13, 1997.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K973014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1997
Decision Date October 20, 1997
Days to Decision 68 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MSV — System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660